The global continuous blood glucose monitoring market size was valued at USD 13.64 billion in 2025 and is projected to grow from USD 15.71 billion in 2026 to USD 48.66 billion by 2034, registering a CAGR of 15.18% during the forecast period from 2026 to 2034. North America dominated the continuous blood glucose monitoring market with a market share of 42.5% in 2025.
The continuous blood glucose monitoring market reflects a shift toward data-driven diabetes management supported by strong public health priorities and institutional backing. The World Health Organization reports a continued rise in diabetes prevalence, which places pressure on healthcare systems to adopt real-time monitoring solutions that reduce complications and hospital burden. The International Diabetes Federation (IDF) 11th Edition Diabetes Atlas (2025) estimates about 589 million adults (ages 20–79) are living with diabetes worldwide in 2024/2025. By 2050 this is projected to rise to ≈853 million if current trends persist. Over 4 in 10 adults with diabetes remain undiagnosed, and low- and middle-income regions carry most of the burden.
Infrastructure improvements, including telehealth expansion and smartphone penetration, further enable continuous blood glucose monitoring use beyond urban hospitals. Companies align devices with digital therapeutics and remote care platforms, which enhances clinical relevance and long-term engagement. At the same time, disparities in reimbursement structures and affordability create uneven adoption patterns between developed and developing regions. Regulatory focus on data security and device accuracy continues to influence product design and approval pathways, which reinforces trust and supports sustained market progression.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Enabled Continuous Glucose Monitoring Systems
The continuous blood glucose monitoring market trends are being driven by the increasing adoption of wearable health technologies, artificial intelligence (AI), and remote diabetes management solutions. Continuous glucose monitoring (CGM) systems are becoming an essential part of diabetes care because they provide real-time glucose readings, trend analysis, and alerts for high or low blood sugar levels without frequent finger-prick testing. Healthcare providers are increasingly recommending CGM devices for both type 1 and type 2 diabetes patients to improve glycemic control and reduce the risk of complications. In addition, integration with insulin pumps, smartphones, and cloud-based health platforms is enabling automated insulin delivery and remote patient monitoring. Manufacturers are also focusing on developing smaller, longer-lasting, and more accurate sensors to improve user comfort and treatment adherence.
These developments indicate that wearable glucose sensors, artificial intelligence, automated insulin delivery, and remote patient monitoring will remain the key Continuous Blood Glucose Monitoring market trends, improving diabetes management, enhancing patient convenience, and driving long-term growth across the global healthcare industry.
Rising Prevalence of Diabetes and Increasing Adoption of Continuous Monitoring Technologies
The continuous blood glucose monitoring market is expanding due to the rising prevalence of diabetes and the growing demand for real-time glucose monitoring solutions. Continuous glucose monitoring (CGM) devices help patients track glucose levels throughout the day, enabling better diabetes management and reducing the risk of hypoglycemia and hyperglycemia. Increasing awareness of preventive healthcare, expanding reimbursement policies, and technological advancements in wearable sensors and smartphone connectivity are further driving adoption. These developments are significantly contributing to continuous blood glucose monitoring market growth as healthcare providers increasingly recommend CGM systems for personalized diabetes care.
High Device Costs and Limited Reimbursement in Emerging Markets
The continuous blood glucose monitoring market faces challenges due to the high cost of CGM devices, sensors, and replacement components, particularly in regions with limited reimbursement coverage. Many patients continue to rely on conventional blood glucose monitoring methods because of affordability concerns and restricted insurance support. In addition, regulatory requirements and the need for continuous sensor replacement increase the overall cost of long-term diabetes management. Recent continuous blood glucose monitoring market analysis indicates that these factors continue to limit adoption across developing healthcare systems and price-sensitive patient populations.
Expansion of AI-Enabled Diabetes Management and Connected Healthcare
The continuous blood glucose monitoring market is expected to benefit from increasing integration of artificial intelligence, digital health platforms, and connected diabetes management solutions. Manufacturers are developing CGM systems that integrate with insulin pumps, mobile applications, and cloud-based analytics to provide personalized treatment recommendations and remote patient monitoring. Rising adoption of telehealth services and growing investments in smart wearable medical devices are also creating significant growth opportunities. These developments are expected to strengthen the continuous blood glucose monitoring market size by improving patient outcomes and expanding access to advanced diabetes care technologies.
Data Accuracy, Interoperability, and Regulatory Compliance
The continuous blood glucose monitoring market continues to face challenges related to maintaining sensor accuracy, ensuring interoperability between connected diabetes devices, and complying with evolving medical device regulations. Manufacturers must continuously improve sensor performance, minimize calibration requirements, and protect patient health data while integrating CGM systems with digital healthcare platforms. According to recent continuous blood glucose monitoring market reports, companies are investing in advanced sensor technologies, cybersecurity measures, and cloud-based analytics to improve device reliability, regulatory compliance, and long-term diabetes management.
Sensors Segment Dominated the Market with 49.6% Share in 2025
The sensors segment dominated the global continuous glucose monitoring market with a 49.6% share in 2025, representing a market value of USD 6.77 billion. The segment is projected to grow at a CAGR of 13.7% during 2026–2034. Its dominance is driven by the recurring replacement requirement of sensors, increasing adoption of real-time glucose monitoring, and growing preference for minimally invasive diabetes management solutions. Continuous technological advancements and rising patient awareness continue to strengthen the segment's market position.
The applicators segment is projected to register steady growth at a CAGR of 12.4% owing to increasing demand for user-friendly sensor insertion systems that improve patient comfort and simplify device application. The device/readers segment continues to witness strong demand due to their role in displaying and storing glucose readings, while transmitters remain an essential component for enabling seamless communication between sensors and monitoring devices.
Request Customizationto receive a tailored report.
4G/Cellular Segment is Projected to Register the Fastest Growth at a CAGR of 14.8%
The 4G/cellular segment is projected to register the fastest growth at a CAGR of 14.8% during 2026–2034. In 2025, the segment accounted for 18.9% of the global continuous glucose monitoring market, with a value of USD 2.58 billion. Growth is driven by increasing demand for remote patient monitoring, real-time data sharing with healthcare providers, and expanding adoption of connected healthcare solutions. Improvements in mobile healthcare infrastructure continue to support the segment's growth.
The Bluetooth segment dominated the market owing to its widespread integration with smartphones, wearable devices, and diabetes management applications, enabling convenient and continuous glucose monitoring. The near field communication (NFC) segment continues to witness steady demand due to its ease of use, low power consumption, and growing adoption in flash glucose monitoring systems.
Type 2 Diabetes Segment is Projected to Register the Fastest Growth at a CAGR of 14.2%
The type 2 diabetes segment is projected to register the fastest growth at a CAGR of 14.2% during 2026–2034. In 2025, the segment accounted for 42.4% of the global continuous glucose monitoring market, with a value of USD 5.78 billion. Growth is driven by the increasing global prevalence of type 2 diabetes, growing awareness of continuous glucose monitoring, and expanding recommendations for CGM use among patients receiving insulin and non-insulin therapies. Rising focus on improving long-term glycemic control continues to support the segment's expansion.
The type 1 diabetes segment dominated the market owing to the routine requirement for continuous glucose monitoring to maintain optimal blood glucose levels and reduce the risk of hypoglycemia and hyperglycemia. Increasing adoption of advanced diabetes management technologies continues to reinforce the segment's leading position.
E-commerce Segment is Projected to Register the Fastest Growth at a CAGR of 15.1%
The e-commerce segment is projected to register the fastest growth at a CAGR of 15.1% during 2026–2034. In 2025, the segment accounted for 32.7% of the global continuous glucose monitoring market, with a value of USD 4.46 billion. Growth is driven by increasing online purchasing of medical devices, expanding digital healthcare platforms, and the convenience of home delivery services. Growing internet penetration and improved access to diabetes care products continue to accelerate the segment's growth.
The pharmacies segment dominated the market owing to their extensive retail network, easy accessibility, and availability of continuous glucose monitoring devices supported by pharmacist guidance and prescription services. The others segment includes hospitals, specialty medical stores, and healthcare distributors that continue to contribute to market growth by improving product availability and supporting patient access to advanced glucose monitoring solutions.
Speak to an Analystto discuss market opportunities.
North America continuous blood glucose monitoring market accounted for 42.5% of the global market, reaching USD 5.80 billion in 2025, and is projected to grow at a CAGR of 12.4% during the forecast period. The market is driven by the rising prevalence of diabetes, increasing adoption of wearable glucose monitoring devices, growing awareness of continuous diabetes management, and favorable reimbursement policies. Ongoing technological advancements and strong investments in digital healthcare continue to support regional market growth.
The US market was valued at USD 4.93 billion in 2025, making it the largest contributor in North America. Increasing prevalence of diabetes, growing adoption of real-time glucose monitoring systems, expanding integration with digital health platforms, and rising demand for minimally invasive monitoring technologies continue to drive market growth.
Canada's market reached USD 0.87 billion in 2025. Growing awareness of diabetes management, increasing access to advanced glucose monitoring technologies, expanding healthcare investments, and rising adoption of wearable medical devices continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe continuous blood glucose monitoring market accounted for 27.3% of the global market, reaching USD 3.72 billion in 2025, and is projected to grow at a CAGR of 11.8% during the forecast period. Rising incidence of diabetes, increasing adoption of continuous glucose monitoring systems, expanding government initiatives for chronic disease management, and growing healthcare expenditure continue to strengthen regional market growth. Continuous innovation in sensor technologies further supports market expansion.
The UK market was valued at USD 0.74 billion in 2025. Increasing adoption of wearable glucose monitoring devices, expanding diabetes awareness programs, growing investments in digital healthcare, and rising demand for personalized disease management continue to support market growth.
Germany market accounted for USD 1.04 billion in 2025. Strong healthcare infrastructure, increasing use of advanced diabetes monitoring technologies, expanding reimbursement support, and rising demand for connected healthcare devices continue to drive market expansion.
Asia Pacific continuous blood glucose monitoring market accounted for 20.4% of the global market, reaching USD 2.78 billion in 2025, and is projected to grow at a CAGR of 15.6% during the forecast period. Rising diabetic population, increasing healthcare expenditure, expanding access to advanced monitoring technologies, and growing awareness of preventive healthcare continue to accelerate regional market growth. Government initiatives promoting diabetes screening and management further strengthen market expansion.
Japan's market generated USD 0.50 billion in 2025. Increasing adoption of digital healthcare solutions, growing aging population, expanding demand for continuous glucose monitoring systems, and rising focus on early disease management continue to support market growth.
China's market accounted for USD 1.17 billion in 2025, representing the largest share within Asia Pacific. Expanding diabetic patient population, increasing investments in healthcare infrastructure, growing adoption of wearable medical devices, and rising awareness of continuous glucose monitoring continue to drive market expansion.
Latin America continuous blood glucose monitoring market accounted for 5.8% of the global market, reaching USD 0.79 billion in 2025, and is projected to grow at a CAGR of 12.7% during the forecast period. Increasing prevalence of diabetes, expanding healthcare infrastructure, growing adoption of advanced glucose monitoring technologies, and rising awareness of chronic disease management continue to support regional market growth.
Brazil market accounted for USD 0.43 billion in 2025. Rising demand for wearable diabetes management devices, increasing healthcare investments, expanding patient awareness programs, and growing access to advanced monitoring solutions continue to support market expansion.
Middle East & Africa continuous blood glucose monitoring market accounted for 4% of the global market, totaling USD 0.55 billion in 2025, and is projected to grow at a CAGR of 11.5% during the forecast period. Increasing diabetes prevalence, expanding healthcare infrastructure, growing awareness of continuous glucose monitoring, and rising investments in medical technology continue to support regional market growth.
The UAE market was valued at USD 0.13 billion in 2025. Increasing adoption of digital healthcare technologies, expanding diabetes management initiatives, growing demand for wearable monitoring devices, and rising healthcare modernization continue to drive market growth.
Africa's market reached USD 0.42 billion in 2025. Improving healthcare accessibility, increasing awareness of diabetes management, expanding investments in medical technology, and growing demand for advanced glucose monitoring solutions continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com